Takara Bio Inc. (JP:4974)
:4974
Want to see JP:4974 full AI Analyst Report?
Total Valuation
Takara Bio Inc. has a market cap or net worth of ¥137.64B. The enterprise value is ¥128.17B.
Market Cap¥137.64B
Enterprise Value¥128.17B
Share Statistics
Takara Bio Inc. has 120,415,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding120,415,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Takara Bio Inc.’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -3.72%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-3.72%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee21.94M
Profits Per Employee-5.22M
Employee Count1,838
Asset Turnover0.30
Inventory Turnover1.73
Valuation Ratios
The current PE Ratio of Takara Bio Inc. is ―. Takara Bio Inc.’s PEG ratio is 0.01.
PE Ratio―
PS Ratio3.43
PB Ratio1.33
Price to Fair Value1.33
Price to FCF-15.37
Price to Operating Cash Flow38.42
PEG Ratio0.01
Income Statement
In the last 12 months, Takara Bio Inc. had revenue of 40.32B and earned -9.60B in profits. Earnings per share was -79.72.
Revenue40.32B
Gross Profit20.26B
Operating Income-4.69B
Pretax Income-9.20B
Net Income-9.60B
EBITDA633.00M
Earnings Per Share (EPS)-79.72
Cash Flow
In the last 12 months, operating cash flow was 3.58B and capital expenditures -12.57B, giving a free cash flow of -8.99B billion.
Operating Cash Flow3.58B
Free Cash Flow-8.99B
Free Cash Flow per Share-74.68
Dividends & Yields
Takara Bio Inc. pays an annual dividend of ¥17, resulting in a dividend yield of 2.18%
Dividend Per Share¥17
Dividend Yield2.18%
Payout Ratio-32.07%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change47.48%
50-Day Moving Average1.14K
200-Day Moving Average958.65
Relative Strength Index (RSI)63.19
Average Volume (3m)357.12K
Important Dates
Takara Bio Inc. upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Takara Bio Inc. as a current ratio of 5.76, with Debt / Equity ratio of 10.59%
Current Ratio5.76
Quick Ratio4.27
Debt to Market Cap0.07
Net Debt to EBITDA-14.96
Interest Coverage Ratio-8.05
Taxes
In the past 12 months, Takara Bio Inc. has paid 353.00M in taxes.
Income Tax353.00M
Effective Tax Rate-0.04
Enterprise Valuation
Takara Bio Inc. EV to EBITDA ratio is 203.43, with an EV/FCF ratio of -14.32.
EV to Sales3.19
EV to EBITDA203.43
EV to Free Cash Flow-14.32
EV to Operating Cash Flow35.95
Balance Sheet
Takara Bio Inc. has ¥20.45B in cash and marketable securities with ¥10.98B in debt, giving a net cash position of ¥9.47B billion.
Cash & Marketable Securities¥20.45B
Total Debt¥10.98B
Net Cash¥9.47B
Net Cash Per Share¥78.63
Tangible Book Value Per Share¥657.47
Margins
Gross margin is 50.25%, with operating margin of -11.63%, and net profit margin of -23.81%.
Gross Margin50.25%
Operating Margin-11.63%
Pretax Margin-22.82%
Net Profit Margin-23.81%
EBITDA Margin1.57%
EBIT Margin-11.63%
Analyst Forecast
The average price target for Takara Bio Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-10.48%
EPS Growth Forecast-1022.09%